Compound regulates genetic risk factor in Parkinson’s disease

Suchi Mittal and colleagues have identified beta-2 adrenergic receptor (β2AR) agonists as compounds that can reduce levels of the alpha-synuclein gene, which has been implicated in increased risk…

This entry was posted in Headlines, News & Events. Bookmark the permalink.

Leave a Reply